Development And Characterization of Inhaled Chitosan Nanoparticles Loaded with Isoniazid

Abstract

The objective of our study is to load first line anti-tubercular drug, Isoniazid in chitosan Nanoparticles in order to enhance bioavailability and to reduce dose frequency. The chitosan nanoparticles containing the drug Isoniazid were prepared by the method of spontaneous emulsification. Chitosan gel containing drug is cross linked with Glutaraldehyde and nanoparticle suspension obtained was centrifuged at 5000 rpm. It was then evaluated for Drug loading, swelling index, Mucoadhesive force, Zeta potential, DLS studies, DSC studies, SEM studies, In vitro Drug release, Pharmacokinetic Studies and Stability studies.Formulation 1(F1) shows maximum Drug Loading, Swelling index and mucoadhesive force. The positive zeta value was obtained for all formulations due to positive charge of polymer used in preparation of dispersion. The DLS plot of Formulations shows that Average particle diameter are in the range of 661.8-823.8nm. The SEM study revealed that the micrographs of cross linked chitosan nanoparticles have smooth surface. The thermogram of the formulations showed the shifting of endotherm. This indicates the possible change in the release kinetics and bioavailability of the drug. In vitro drug releases was found to be maximum for formulation F6. Pharmacokinetic evaluation shows all the formulation shows first order rate release profile and release mechanism from nanoparticles is diffusion controlled. Stability studies indicated that the developed chitosan nanoparticles are physically and chemically stable and retain their pharmaceutical properties at various environmental conditions over a period of 3 months.

References

  • Ahsan, F. Rivas, I.P. Khan, M.A., Torres Suarez Al., (2002). Targeting to macrophages: role of physicochemical properties of particulate carrier’s liposomes and microspheres on the phagocytosis by macrophages. Control Rel. 79, 29 – 40. http://dx.doi.org/10.1016/S0168-3659(01)00549-1
  • Drug delivery Nanoparticles formulaion and charecterisation edited by Yashwant pathak and Deepak Thassu – Vol 191 –Page no 9-11
  • Grenha, A., Remunan-Lopez, C., Carvalho, E.L., Seijo, B., (2008) Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins, Eur. J. Pharm. Biopharm. 69, 83–93. http://dx.doi.org/10.1016/j.ejpb.2007.10.017
  • Kawashima, Y. Serigano, T. Hino, T. Yamamoto, H. Takeuchi, H. (1998) A newpowder design method to improve inhalation efficiency of pranlukasthydrate dry powder aerosols by surface modification with hydroxyl propyl methyl cellulose phthalate nanospheres, Pharm. Res. 15 (11) 1748–1752.
  • Nasti, A., Ziaki N. M., de Leonardis, P., Ungphaiboon, S. Sansongsaks, P., Rimoli, M. G., Tirelli, N. Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Pharma. Res., 26 (8), 1918 –1930. http://dx.doi.org/10.1007/s11095-009-9908-0
  • Pandey, R. and Khuller, G. K. (2004) Polymer based drug delivery systems for mycobacterial infections. Current Drug Delivery 1,195 – 201.
  • Papadimitriou, S., Dimitrios, B., Konstantinos A., Evangelos, K., Manolis G., (2008) Chitosan nanoparticles loaded with dorzolamide and pramipexole. Cors. o. vol. 73(1),44–54. http://dx.doi.org/10.1016/j.carbpol.2007.11.007
  • Rao, G.C., Kumar, M.S., Mathivanan, N. Rao, M.E., (2004) Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems. Pharmazie 59, 5 – 9.
  • Sabitha, P. Vijaya Ratna J. and Ravindra Reddy K. (2010) Design and evaluation of controlled release chitosan-calcium alginate microcapsules of anti tubercular drugs for oral use. Int. J. Chemtech Res. 2(1), 88–98.
  • Sahoo, S.K., Praveen, S. (2007) The present and future of nanotechnology in human health care. Nanomedicine: Nanotechnology. Biol. Med. 3 20– 31. http://dx.doi.org/10.1016/j.nano.2006.11.008
  • Wilson, B., Samanta, M. K., Santhi, K., Kumar, K.P., Ramasamy, M., Suresh, B., (2010) Chitosan nanoparticles as a new delivery system for the anti Alzheimer’s drug tacrine. Namomedicine. 6, 144–152. http://dx.doi.org/10.1016/j.nano.2009.04.001

  • Published Date : 2014-11-30